Long-Term Survival Following Multimodal Therapy with Sunitinib and Surgery for Recurrent Duodenal Gastrointestinal Stromal Tumor
This case highlights the potential of combining sunitinib with surgery to manage drug-resistant GIST. Localized surgical resection of resistant lesions, integrated with systemic therapy, may offer prolonged survival in selected patients. Further studies are needed to define the optimal role of surgery in this context.
Authors
- Kotaro Yamashita (ORCID: https://orcid.org/0000-0001-9538-5705)
- Yuichiro Doki
- Eiichi Mori
- Koji Tanaka (ORCID: https://orcid.org/0000-0001-5178-9388)
- Tomomi Fujii (ORCID: https://orcid.org/0000-0002-7207-4127)
- Kiyokazu Nakajima (ORCID: https://orcid.org/0000-0001-8635-7585)
- Tomoki Makino (ORCID: https://orcid.org/0000-0001-7918-4217)
- Takuro Saito (ORCID: https://orcid.org/0000-0002-1733-5064)
- Hidetoshi Eguchi (ORCID: https://orcid.org/0000-0002-2318-1129)
- Manatsu Mizuno
- Takaomi Hagi (ORCID: https://orcid.org/0000-0002-4028-2714)
- Yoshito Tomimaru (ORCID: https://orcid.org/0000-0002-4432-060X)
- Yukinori Kurokawa
- Tsuyoshi Takahashi (ORCID: https://orcid.org/0000-0003-2397-1478)
- Kota Momose
Institutions
- The University of Osaka (JP)
Publication Details
- Journal
- Surgical Case Reports
- Published
- 2025-01-01
- DOI
- https://doi.org/10.70352/scrj.cr.25-0260
- Primary Topic
- Gastrointestinal Tumor Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00